Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study
Nutrition, Metabolism and Cardiovascular Diseases · 2026
DOI: 10.1016/j.numecd.2025.104284 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026. Verfasst von Alfredo Caturano und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, 80138, Italy; Department of Human Sciences and…. Hauptthemen laut MEDLINE: Metformin, Benzhydryl Compounds, Glucosides, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: University of Campania Luigi Vanvitelli.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, 80138, Italy; Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma University, Rome,…
- Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, 80138, Italy.
- Department of Physical and Mental Health and Preventive Medicine, Medical Statistics Unit, University of Campania "Luigi Vanvitelli", Piazza Luigi Miraglia 2, 80138, Naples, Italy.
- Azienda Ospedaliera Regionale San Carlo, Potenza, 85100, Italy.
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, 80138, Italy.
- Department of Biology, College of Science and Technology, Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA, 19122, USA; Division of Cardiology, Department of Medical Trans…
Förderung
- University of Campania Luigi Vanvitelli
Zitieren
APA
Caturano, A., Galiero, R., Simeon, V., Acierno, C., Nilo, D., Marrone, A., Trotta, M. C., Vetrano, E., Sardu, C., Russo, V., Conte, C., D'Onofrio, N., Chiodini, P., Marfella, R., Balestrieri, M. L., D'Amico, M., Rinaldi, L., & Sasso, F. C. (2026). Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.104284
Vancouver
Caturano A, Galiero R, Simeon V, Acierno C, Nilo D, Marrone A, et al. Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study. Nutrition, Metabolism and Cardiovascular Diseases. 2026. doi:10.1016/j.numecd.2025.104284
BibTeX
@article{Caturano2026,
author = {Caturano, Alfredo and Galiero, Raffaele and Simeon, Vittorio and Acierno, Carlo and Nilo, Davide and Marrone, Aldo and Trotta, Maria Consiglia and Vetrano, Erica and Sardu, Celestino and Russo, Vincenzo and Conte, Caterina and D'Onofrio, Nunzia and Chiodini, Paolo and Marfella, Raffaele and Balestrieri, Maria Luisa and D'Amico, Michele and Rinaldi, Luca and Sasso, Ferdinando Carlo},
title = {Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2026},
doi = {10.1016/j.numecd.2025.104284}
}
EUVIMED